1. Home
  2. CCAP vs VALN Comparison

CCAP vs VALN Comparison

Compare CCAP & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crescent Capital BDC Inc.

CCAP

Crescent Capital BDC Inc.

HOLD

Current Price

$11.81

Market Cap

418.9M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.23

Market Cap

495.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCAP
VALN
Founded
2015
2012
Country
United States
France
Employees
250
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.9M
495.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CCAP
VALN
Price
$11.81
$5.23
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$15.86
$15.50
AVG Volume (30 Days)
206.9K
23.8K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
12.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
$14.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.64
$4.75
52 Week High
$16.04
$12.25

Technical Indicators

Market Signals
Indicator
CCAP
VALN
Relative Strength Index (RSI) 61.86 52.41
Support Level $10.83 $5.10
Resistance Level $13.57 $5.52
Average True Range (ATR) 0.26 0.13
MACD 0.09 0.05
Stochastic Oscillator 98.26 71.68

Price Performance

Historical Comparison
CCAP
VALN

About CCAP Crescent Capital BDC Inc.

Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: